Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 5
Submit an article Journal homepage
128
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Indicators of Post-Operative Intraocular Pressure Elevation after Naïve Fluocinolone Acetonide Surgical Implantation

Aaron J. SadowskyDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USAView further author information
, MS,
Paula E. PecenDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USACorrespondence[email protected]
View further author information
, MD,
Eric FeinsteinDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USAView further author information
, MD &
Alan G. PalestineDepartment of Ophthalmology, University of Colorado School of Medicine, Aurora, CO, USAView further author information
, MD
Pages 828-832 | Received 06 Dec 2018, Accepted 24 May 2019, Published online: 13 Aug 2019

REFERENCES

  • Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711–1720. doi:10.1016/S0140-6736(04)16257-0.
  • Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002;46:556–562.
  • Francois J. Cortisone et tension oculaire. Ann Ocul (Paris). 1954;187:805–816.
  • Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500–507.
  • Merayo-Lloves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300–304. doi:10.1159/000027443.
  • Panek WC, Holland GN, Lee DA, et al. Glaucoma in patients with uveitis. British J Ophthalmol. 1990;74:223–227. doi:10.1136/bjo.74.4.223.
  • Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000;130:492–513.
  • Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol Vis Sci. 1965;4:198–205.
  • Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. I. the effect of dexamethasone in the normal eye. Arch Ophthalmol. 1963;70:482–491.
  • Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. Ii. the effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963;70:492–499.
  • Roth DB, Verma V, Realini T, et al. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection. Ophthalmology. 2009;116:455–460. doi:10.1016/j.ophtha.2008.10.002.
  • Thorne JE, Sugar EA, Holbrook JT, et al. Periocular triamcinolone vs. intravitreal triamcinolone vs. intravitreal dexamethasone implant for the treatment of uveitic macular edema: the PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) trial. Ophthalmology. 2019;126:283–295. doi:10.1016/j.ophtha.2018.08.021.
  • Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol. 2007;125:1478–1485. doi:10.1001/archopht.125.11.ecs70063.
  • Parekh A, Srivastava S, Bena J, et al. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant. JAMA Ophthalmol. 2015;133:568–573. doi:10.1001/jamaophthalmol.2015.51.
  • Holbrook JT, Sugar EA, Burke AE, et al. Dissociations of the fluocinolone acetonide implant: the multicenter uveitis steroid treatment (MUST) trial and follow-up study. Am J Ophthalmol. 2016;164:29–36.
  • Jaffe GJ, Ben-Nun J, Guo H, et al. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Ophthalmology. 2000;107:2024–2033.
  • Jaffe GJ, McCallum RM, Branchaud B, et al. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis. Ophthalmology. 2005;112:1192–1198. doi:10.1016/j.ophtha.2005.03.013.
  • Kempen JH, Altaweel MM, Holbrook JT, et al. Association between long-lasting intravitreous fluocinolone acetonide implant vs systemic anti-inflammatory therapy and visual acuity at 7 years among patients with intermediate, posterior, or panuveitis. Jama. 2017;317:1993–2005. doi:10.1001/jama.2017.5103.
  • Friedman DS, Holbrook JT, Ansari H, et al. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial. Ophthalmology. 2013;120:1571–1579. doi:10.1016/j.ophtha.2013.01.025.
  • Crawley L, Zamir SM, Cordeiro MF, et al. Clinical options for the reduction of elevated intraocular pressure. Ophthalmol Eye Dis. 2012;4:43–64. doi:10.4137/OED.S4909.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.